"We believe that 2025 will be a pivotal year for SELLAS as we continue to advance our clinical stage portfolio of novel therapeutics for hematologic malignancies,” said Angelos ...

In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...

Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic ...

Results from a clinical trial ... Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5, 2024 — The first comprehensive map of the dramatic changes that take ...

Jimmy Cragg's symptoms were initially dismissed as a virus or tonsillitis until a bruise on his back — a sign of low platelet ...

The Arizona Cancer Foundation for Children helps support families with sick kids feel normal and find support. Here's how the ...

We talk with members of Everett Fire about their mission to raise $100,000 for the Leukemia and Lymphoma Society ahead of the ...

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells causing Lupus. First approved for treating leukemia in 2017, CAR-T cell therapy ...

After overcoming a life-threatening superbug, Ben "Verse" Mount now faces a diagnosis of acute monoblastic leukemia and has ...

Eunice S. Wang, MD, discusses a retrospective study of 105 patients diagnosed with secondary acute myeloid leukemia.

Nina Karlinsky raised money for the Children's Miracle Network until her death from cancer. Now, her mother is carrying on her legacy.

An expert spoke with CURE® about the importance of information that can be gained from genetic testing for patients with ...